Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
362 studies found for:    "keratitis-ichthyosis-deafness syndrome" OR "Keratitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Collagen Cross-linking in Infectious Keratitis Trial
Conditions: Infectious Keratitis;   Bacterial Keratitis;   Fungal Keratitis
Intervention: Procedure: Collagen cross-linking
2 Recruiting Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
Conditions: Neurotrophic Keratitis;   Keratitis;   Corneal Ulcer
Interventions: Drug: rhNGF 10 µg/ml eye drops solution;   Drug: rhNGF 20 µg/ml eye drops solution;   Drug: Placebo
3 Not yet recruiting Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)
Conditions: Bacterial Keratitis;   Fungal Keratitis
Interventions: Device: Crosslinking;   Drug: antibiotic treatment
4 Recruiting Matrix Therapy And Bacterial Keratitis
Condition: Bacterial Keratitis
Interventions: Device: RGTA OTR4120 (CACICOL20);   Device: physiological salt solution
5 Completed The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)
Condition: Herpes Simplex Keratitis
Intervention:
6 Recruiting The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis
Condition: Herpes Simplex Keratitis
Intervention: Procedure: Corneal sampling
7 Recruiting Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
Condition: Infectious Keratitis
Intervention: Other: Ultraviolet-A and riboflavin
8 Not yet recruiting Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 Neurotrophic Keratitis
Condition: Neurotrophic Keratitis
Interventions: Drug: rhNGF 20µg/ml;   Drug: Placebo Vehicle
9 Recruiting Pseudomonal Type Three Secretion System and Contact Lens Associated Microbial Keratitis
Condition: Keratitis; Infectious Disease (Manifestation)
Intervention:
10 Recruiting Contact Lenses and Infiltrative Keratitis
Condition: Keratitis
Intervention: Device: senofilcon A
11 Recruiting Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
Conditions: Keratitis;   Corneal Ulcer
Intervention: Device: T4020
12 Completed Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis
Conditions: Blepharitis;   Conjunctivitis;   Keratitis
Interventions: Drug: Moxifloxacin and Dexamethasone combined;   Drug: Moxifloxacin;   Drug: Dexamethasone
13 Completed Microbiological Keratitis in a Countryside City of Brazil
Condition: Keratitis
Intervention:
14 Terminated
Has Results
Cross Linking for Treatment of Corneal Infection
Condition: Infectious Keratitis
Interventions: Drug: riboflavin;   Device: UVX Light
15 Completed Herpetic Eye Disease Study (HEDS) II
Conditions: Keratitis, Herpetic;   Ocular Herpes Simplex;   Herpes Simplex
Interventions: Behavioral: Stress;   Drug: Acyclovir
16 Unknown  Herpetic Eye Disease Study (HEDS) I
Conditions: Keratitis, Herpetic;   Ocular Herpes Simplex
Interventions: Drug: Prednisolone Phosphate;   Drug: Acyclovir
17 Completed Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses
Condition: Keratitis
Intervention: Device: Use of B+L Biotrue multipurpose solution (MPS) with PureVision contact lenses
18 Completed Evaluation and Treatment of Patients With Corneal and External Diseases
Conditions: Blepharitis;   Conjunctivitis;   Corneal Disease;   Dacryoadenitis;   Dacryocystitis;   Keratitis
Intervention:
19 Completed Screening for NEI Clinical Studies
Conditions: Conjunctivitis;   Iritis;   Keratitis;   Retinitis;   Uveitis
Intervention:
20 Unknown  Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Conditions: Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions: Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years